Chronic skin disease (CSD) has devastating effects on the physiological, psychological and social aspects of people, impacting on quality of life (Jafferany & Pastolero, 2018;Parna et al., 2015). And the psychosocial and occupational effects of CSD are often comparable, if not greater, than those of other chronic diseases (Hong et al., 2008). The lifetime prevalence of skin diseases, including eczema (14.2%), urticaria (9.2%), atopic dermatitis (7.9%), psoriasis (5.2%), vitiligo (1.9%) and other diseases (11.3%), was reported for